Catégories
- De nouvelles Haomei (307)
Dans l'industrie pharmaceutique, l'emballage n'est pas seulement le “manteau extérieur” de drogue, mais aussi un obstacle important pour protéger la qualité et la sécurité des médicaments. Comme matériau clé pour l'emballage pharmaceutique, La performance de la feuille de cloques de formation à froid est directement liée à la stabilité et à l'efficacité des médicaments.
As a professional manufacturer of cold forming blister foil for pharmaceutical packaging, we are committed to providing high-quality products to pharmaceutical manufacturers. Our advantages are also significant. In terms of production equipment, we have introduced internationally advanced aluminum foil rolling, coating and slitting equipment, and the production process is fully automated, which not only improves production efficiency, but also ensures the stability and consistency of product quality. The performance differences of each batch of products are controlled within a very small range.
Core performance indicators of the cold forming blister foil pharmaceutical packaging product
– Performances de la barrière
The product adopts high-purity aluminum substrate and special coating composite process. It has been verified by a third-party testing agency that the oxygen permeability is ≤0.1cm³/(m²・24h・0.1MPa) and the water vapor permeability is ≤0.1g/(m²・24h). It can effectively block environmental factors such as oxygen, water vapor and ultraviolet rays, delay the oxidation and deliquescence of drugs, and meet the requirements of the “Guidelines for Compatibility Testing of Pharmaceutical Packaging Materials and Drugs”.
– Forming adaptability
The aluminum foil substrate is processed by multiple rolling processes, and the thickness deviation is controlled within ±3μm. The anti-rupture strength during cold forming is ≥12N/15mm. It can adapt to the packaging needs of tablets, capsules and special-shaped preparations with a diameter of 3-20mm. The qualified rate of the sealing integrity test after forming is 100%.
– Safety and Compliance
The raw materials are made of pharmaceutical aluminum foil that meets the GB/T 31982-2015 standard, with a heavy metal content of ≤0.001% and a volatile organic compound residue of <5mg/m². The production process adopts a GMP standard clean workshop, and HACCP quality control is implemented throughout the process. The products are sterilized with ethylene oxide, and the sterility test results meet the requirements of YY/T 0681.1.
Avantages de cold forming blister foil pour le conditionnement pharmaceutique:
– Pour prolonger la durée de conservation: Due to its excellent barrier properties, cold formed blister foil can effectively extend the shelf life of drugs and reduce drug waste.
– Improve safety: Good sealing and mechanical strength can reduce the risk of damage to drugs during transportation and storage.
Applications
Cold-forming blister foil is mainly used in the following fields:
– Solid drugs: comme les tablettes, capsules, etc..
– Medical devices: some disposable medical devices.
– Nutritional supplements: such as vitamins, minerals, etc..
Cold forming blister foil for pharmaceutical packaging plays an important role in pharmaceutical packaging. With its superior physical and chemical properties, it has become an indispensable packaging material in the pharmaceutical industry.